Philip P. Connell to Female
This is a "connection" page, showing publications Philip P. Connell has written about Female.
Connection Strength
0.315
-
Elevated Radiation Therapy Toxicity in the Setting of Germline PTEN Mutation. Pract Radiat Oncol. 2019 Nov; 9(6):492-495.
Score: 0.034
-
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4493-4500.
Score: 0.029
-
Small molecule derived from a natural product that mitigates radiation injury. Proc Natl Acad Sci U S A. 2013 Nov 12; 110(46):18355-6.
Score: 0.023
-
Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1147-53.
Score: 0.017
-
Radiotherapy for pediatric brain tumors: when and how. Expert Rev Anticancer Ther. 2007 Dec; 7(12 Suppl):S69-77.
Score: 0.015
-
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007 Jun; 30(3):258-63.
Score: 0.015
-
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol. 2006 May; 28(5):1113-9.
Score: 0.014
-
Long term follow up of nasolacrimal intubation in adults. Br J Ophthalmol. 2006 Apr; 90(4):435-6.
Score: 0.014
-
Investigating ethnic differences in sexual health: focus groups with young people. Sex Transm Infect. 2004 Aug; 80(4):300-5.
Score: 0.012
-
qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat. 2022 Jan; 191(2):335-344.
Score: 0.010
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.010
-
Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2001 Aug 01; 50(5):1145-53.
Score: 0.010
-
Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2001 Aug 01; 50(5):1154-60.
Score: 0.010
-
Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol. 2000 Oct; 79(1):79-85.
Score: 0.009
-
Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma? Int J Cancer. 2000 Aug 20; 90(4):224-30.
Score: 0.009
-
Radiation-Induced Sarcoma After Heterotopic Ossification Prophylaxis: A Case Report. JBJS Case Connect. 2019 Dec; 9(4):e0146.
Score: 0.009
-
Race and clinical outcome in endometrial carcinoma. Obstet Gynecol. 1999 Nov; 94(5 Pt 1):713-20.
Score: 0.009
-
The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol. 1999 Jul; 74(1):74-9.
Score: 0.009
-
Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
Score: 0.008
-
An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. J Thorac Oncol. 2013 Feb; 8(2):147-51.
Score: 0.005
-
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol. 2012 Feb; 7(2):376-81.
Score: 0.005
-
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012 Jun 01; 118(11):2962-70.
Score: 0.005
-
Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
Score: 0.005
-
The Yin and Yang of treating BRCA-deficient tumors. Cell. 2008 Mar 21; 132(6):919-20.
Score: 0.004
-
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):515-22.
Score: 0.004
-
Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol. 2001 Aug; 82(2):338-43.
Score: 0.002
-
Analysis of the role of adjuvant chemotherapy for invasive carcinoma of the esophagus. Am J Clin Oncol. 2000 Dec; 23(6):554-8.
Score: 0.002
-
Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol. 2000 Oct; 23(5):476-80.
Score: 0.002
-
Synchronous ovarian and endometrial malignancies. Am J Clin Oncol. 2000 Oct; 23(5):521-5.
Score: 0.002
-
One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy. Gynecol Oncol. 2000 Jul; 78(1):32-8.
Score: 0.002
-
Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma. Gynecol Oncol. 2000 Jan; 76(1):67-72.
Score: 0.002
-
Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999 Aug; 22(4):338-43.
Score: 0.002
-
External pelvic radiation therapy in stage IC endometrial carcinoma. Obstet Gynecol. 1999 Apr; 93(4):599-602.
Score: 0.002
-
What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy? Radiat Oncol Investig. 1999; 7(6):353-9.
Score: 0.002
-
Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 1998 Nov; 71(2):151-8.
Score: 0.002